Literature DB >> 26603137

Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.

Jennifer H Benbow1, Kyle J Thompson2, Heidi L Cope1, Elizabeth Brandon-Warner1, Catherine R Culberson1, Krista L Bossi3, Ting Li1, Mark W Russo3, Keith S Gersin2, Iain H McKillop2, Andrew S deLemos3, Laura W Schrum4.   

Abstract

Obesity is an independent risk factor for the development of liver fibrosis/cirrhosis and hepatocellular carcinoma (HCC). Tenascin-C (TnC), an extracellular matrix protein, is transiently expressed during tissue injury and plays a role in fibrogenesis and tumorigenesis. However, the mechanistic role of TnC signaling in the development of HCC remains unknown. We developed a diet-induced obesity HCC mouse model and examined TnC expression and liver injury. To determine the cellular mechanism of TnC signaling in promoting inflammation and hepatocyte epithelial-mesenchymal transition and migration, we used primary hepatocytes and hepatoma and macrophage cell lines. Further, to determine whether elevated TnC expression correlated with obesity-associated HCC, we measured plasma TnC in obese patients with various levels of liver injury. Increased tissue inflammation accompanied with elevated hepatic stellate cell-derived TnC and Toll-like receptor 4 expression was observed in the diet-induced obesity HCC animal model. In vitro studies found enhanced Toll-like receptor 4 signaling activated by TnC, promoting an increased inflammatory response, hepatocyte transformation, and migration. Further, obese patients with cirrhosis alone and in combination with HCC showed significant increases in plasma TnC compared with healthy volunteers and patients with less severe liver injury. Overall, these studies suggest TnC/Toll-like receptor 4 signaling as an important regulator in HCC; inhibiting this signaling axis may be a viable therapeutic target for impeding HCC.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26603137     DOI: 10.1016/j.ajpath.2015.09.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis.

Authors:  Elizabeth Brandon-Warner; Jennifer H Benbow; Jacob H Swet; Nicole A Feilen; Catherine R Culberson; Iain H McKillop; Andrew S deLemos; Mark W Russo; Laura W Schrum
Journal:  Hum Gene Ther       Date:  2018-03-01       Impact factor: 5.695

Review 2.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

3.  Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.

Authors:  Jennifer H Benbow; April D Elam; Krista L Bossi; Danae L Massengill; Elizabeth Brandon-Warner; William E Anderson; Catherine R Culberson; Mark W Russo; Andrew S deLemos; Laura W Schrum
Journal:  Dig Dis Sci       Date:  2018-01-12       Impact factor: 3.199

Review 4.  A Systematic Review and Meta-Analysis of Proteomics Literature on the Response of Human Skeletal Muscle to Obesity/Type 2 Diabetes Mellitus (T2DM) Versus Exercise Training.

Authors:  Kanchana Srisawat; Sam O Shepherd; Paulo J Lisboa; Jatin G Burniston
Journal:  Proteomes       Date:  2017-11-11

5.  Suppression of hepatic dysfunction in tenascin‑X‑deficient mice fed a high‑fat diet.

Authors:  Shinsaku Yamaguchi; Kohei Kawakami; Kazumi Satoh; Naoki Fukunaga; Kazuhito Akama; Ken-Ichi Matsumoto
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

6.  Hepatic transcriptome profile of sheep (Ovis aries) in response to overgrazing: novel genes and pathways revealed.

Authors:  Weibo Ren; Warwick Badgery; Yong Ding; Huiqin Guo; Yang Gao; Jize Zhang
Journal:  BMC Genet       Date:  2019-07-04       Impact factor: 2.797

7.  Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis.

Authors:  Alex Claveria-Cabello; Leticia Colyn; Iker Uriarte; Maria Ujue Latasa; Maria Arechederra; Jose M Herranz; Laura Alvarez; Jesus M Urman; Maria L Martinez-Chantar; Jesus M Banales; Bruno Sangro; Krista Rombouts; Julen Oyarzabal; Jose J G Marin; Carmen Berasain; Matias A Avila; Maite G Fernandez-Barrena
Journal:  Cancers (Basel)       Date:  2020-12-13       Impact factor: 6.639

Review 8.  Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.

Authors:  Takuya Iyoda; Motomichi Fujita; Fumio Fukai
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

Review 9.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  Cardiovascular Risk Factors and Differential Transcriptomic Profile of the Subcutaneous and Visceral Adipose Tissue and Their Resident Stem Cells.

Authors:  Gemma Arderiu; Carmen Lambert; Carlos Ballesta; Fabrizio Moscatiello; Gemma Vilahur; Lina Badimon
Journal:  Cells       Date:  2020-10-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.